JP Stock MarketDetailed Quotes
4883 Modalis Therapeutics
- 133
- +15+12.71%
20min DelayNot Open Nov 19 15:30 JST
7.85BMarket Cap-1721P/E (Static)
136High119Low26.65MVolume121Open118Pre Close3.47BTurnover20352wk High53.94%Turnover Ratio59.00MShares6252wk Low-64.98EPS TTM6.57BFloat Cap4070Historical HighLossP/E (Static)49.41MShs Float62Historical Low-77.24EPS LYR14.41%Amplitude--Dividend TTM6.77P/B100Lot Size--Div YieldTTM
About Modalis Therapeutics Company
Modalis Therapeutics Corp is a drug development company. It is engaged in research and development of Gene Therapy using core platform technology, non-editing CRISPR technology (CRISPR-GNDM). The company's products in pipeline are MDL-201, MDL-202, MDL-204, MDL-205, MDL-206, MDL-101, and MDL-102.
Company Profile
Symbol4883
Company NameModalis Therapeutics
Founded2016-01-14
MarketTSE Growth
Employees37
Fiscal Year Ends12-31
Address16-5 Nihombashi-Kabuto-cho Chuo-ku
Zip Code103-0023
Phone03-6822-4584
Websitemodalistx.com
Company Executives
- Name
- Position
- Salary
- Haruhiko Morita
- Representative Director and President
- --
- Miyuki Shimane
- Independent Director
- --
- Joseph McCracken
- Independent Director
- --
- Hideki Takeda
- Independent Director
- --
- Toshio Furuta
- Independent Director
- --
- Teruhisa Tashima
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
JP
Overall
Symbol
Latest Price
% Chg
No Data